ADD stands for Attention Deficit Disorder. It was the official name used for a condition involving persistent trouble with focus, organization, and concentration. While many people still use the term, ADD is no longer the clinical diagnosis. The current name, used since the 1990s and reinforced in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), is Attention-Deficit/Hyperactivity Disorder, or ADHD.
Why the Name Changed to ADHD
ADD was introduced as a formal diagnosis in the early 1980s to describe people who had significant attention problems but weren’t necessarily hyperactive. Over time, researchers recognized that attention difficulties and hyperactivity-impulsivity are part of the same condition, just expressed in different ways. The American Psychiatric Association consolidated everything under one umbrella: ADHD, with three presentations.
What used to be called ADD is now officially “ADHD, predominantly inattentive presentation.” The two other presentations are predominantly hyperactive-impulsive and combined (both inattentive and hyperactive-impulsive symptoms). So when someone says they have ADD, they’re typically describing what clinicians now classify as the inattentive form of ADHD.
What Inattentive ADHD Looks Like
People with the inattentive presentation don’t fit the stereotype of the restless, impulsive kid bouncing off the walls. Instead, the hallmark signs are internal: difficulty sustaining attention during tasks, losing things frequently, being easily distracted, struggling to follow through on instructions, and appearing not to listen even during direct conversation. Forgetfulness in daily activities, trouble organizing tasks, and avoiding work that requires sustained mental effort are also core symptoms.
These symptoms need to be present in more than one setting (school and home, for instance) and must interfere with daily functioning to qualify for a diagnosis. Healthcare providers use the DSM-5 criteria, which require at least six of these inattentive symptoms in children or five in adults, persisting for six months or more.
Why It’s Often Missed in Girls
The inattentive presentation is significantly underdiagnosed, particularly in girls and women. Research from the Cleveland Clinic shows that girls are 16 times less likely than boys to receive an ADHD diagnosis and treatment. When girls do get diagnosed, studies suggest they’re more likely to have the inattentive type, while hyperactivity and impulsivity are more common in boys.
The reasons are partly cultural. Expectations that girls will be quieter and more reserved mean that a girl’s inability to focus often gets dismissed as daydreaming or spaciness. Inattentiveness doesn’t disrupt a classroom or home life the way hyperactivity does, which makes it easier for parents and teachers to overlook. Even hyperactive or impulsive behaviors in girls may be chalked up to being “overemotional” rather than recognized as a sign of ADHD.
What Happens in the Brain
ADHD involves differences in how the brain regulates attention and executive functions like planning, prioritizing, and impulse control. Two chemical messengers, dopamine and norepinephrine, play central roles. These chemicals help brain circuits that connect the front of the brain (responsible for decision-making and focus) with deeper structures involved in motivation and reward. In people with ADHD, signaling along these pathways is less efficient, which is why staying focused on tasks that aren’t immediately rewarding feels so much harder.
This is also why stimulant medications, which might seem counterintuitive, work. They increase the availability of dopamine and norepinephrine in these circuits, effectively turning up the signal so the brain can sustain attention more easily.
How Common It Is
ADHD affects roughly 10.2% of American adults, up from 6.1% two decades ago. That increase reflects broader awareness and better screening rather than a sudden spike in the condition itself. The median age of diagnosis in children is 6 years old, though milder cases tend to be caught later, around age 7, while more severe cases are often identified by age 4.
Many adults living with the inattentive presentation weren’t diagnosed as children at all. They may have spent years assuming they were lazy, scatterbrained, or simply not trying hard enough before learning there was a neurological explanation for their struggles.
Treatment for the Inattentive Type
Treatment typically involves some combination of medication and behavioral strategies. The FDA has approved two classes of medication for ADHD: stimulants and non-stimulants. Stimulants, which contain forms of methylphenidate or amphetamine, are the most commonly prescribed and tend to have a calming, focusing effect despite their name. Non-stimulant options are also available and may be preferred for people who experience side effects from stimulants or have other health considerations.
Beyond medication, many people benefit from cognitive behavioral therapy tailored to ADHD, which helps build practical skills around organization, time management, and breaking tasks into smaller steps. External tools like planners, timers, and structured routines can also make a meaningful difference, especially for the inattentive presentation where the core challenge is staying on track rather than sitting still.
The inattentive type responds well to treatment, but because it’s quieter and less obvious than hyperactive ADHD, the biggest barrier for many people is simply getting recognized and diagnosed in the first place.